نتائج البحث - "Gamelin, Laurence"

1

Academic Journal

P1388: EFFECTIVENESS AND SAFETY OUTCOMES IN PATIENTS WITH EBV+ PTLD TREATED WITH ALLOGENEIC EBV-SPECIFIC T-CELL IMMUNOTHERAPY (TABELECLEUCEL) UNDER AN EXPANDED ACCESS PROGRAM IN EUROPE

المؤلفون: Choquet, Sylvain, Clark, Andrew, Renard, Cécile, Uttenthal, Ben, Chaganti, Sridhar, Ulrich Trappe, Ralf, Comoli, Patrizia, Duan, Xinyuan, Xing, Baodong, Wu, Charley, Gamelin, Laurence, Terwey, Jan-Henrik, Friedetzky, Anke, Dierickx, Daan

المصدر: HemaSphere ; volume 7, issue S3, page e8073255 ; ISSN 2572-9241

الاتاحة: http://dx.doi.org/10.1097/01.hs9.0000972440.80732.55
https://journals.lww.com/10.1097/01.HS9.0000972440.80732.55

View record in BASE

2

Academic Journal

P1390: NEW AND UPDATED RESULTS FROM A MULTICENTER OPEN-LABEL GLOBAL PHASE3 STUDY OF TAB-CEL FOR EBV+PTLD FOLLOWING HCT OR SOT AFTER FAILURE OF RITUXIMAB OR RITUXIMAB+CHEMOTHERAPY (ALLELE)

المؤلفون: Kris Michael, Mahadeo, Robert, Baiocchi, Amer, Beitinjaneh, Sridhar, Chaganti, Choquet, Sylvain, Dierickx, Daan, Rajani, Dinavahi, Gamelin, Laurence, Ghobadi, Armin, Norma, Guzman-Becerra, Manher, Joshi, Aditi, Mehta, Sarah, Nikiforow, Ran, Reshef, Wei, Ye, Susan, Prockop

المصدر: HemaSphere ; volume 7, issue S3, page e0490265 ; ISSN 2572-9241

الاتاحة: http://dx.doi.org/10.1097/01.hs9.0000972448.04902.65
https://journals.lww.com/10.1097/01.HS9.0000972448.04902.65

View record in BASE

3

Academic Journal

New and Updated Results from a Multicenter, Open-Label, Global Phase 3 (P3) Study of Tabelecleucel (Tab-cel) for Epstein–Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) Following Allogeneic Hematopoietic Cell (HCT) or Solid Organ Transplant (SOT) after Failure of Rituximab (R) or Rituximab and Chemotherapy (R+CT) (ALLELE)

المؤلفون: Beitinjaneh, Amer, Baiocchi, Robert, Chaganti, Sridhar, Choquet, Sylvain, Dierickx, Daan, Dinavahi, Rajani, Gamelin, Laurence, Ghobadi, Armin, Guzman-Becerra, Norma, Joshi, AJ, Mahadeo, Kris Michael, Mehta, Dr. Aditi, Nikiforow, Sarah, Reshef, Ran, Ye, Wei, Prockop, Susan

المصدر: Transplantation and Cellular Therapy ; volume 29, issue 2, page S21-S22 ; ISSN 2666-6367

الاتاحة: http://dx.doi.org/10.1016/s2666-6367(23)00094-5
https://api.elsevier.com/content/article/PII:S2666636723000945?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S2666636723000945?httpAccept=text/plain

View record in BASE

4

Academic Journal

Exploring the Impact of Humoral Immunogenicity with Tabelecleucel (Tab-cel) for the Treatment of Epstein–Barr Virus Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) Following Hematopoietic Stem Cell Transplantation (HCT) and Solid Organ Transplantation (SOT)

المؤلفون: Spindler, Tassja J., Ruiz, Fiona, Jehng, Tiffany, Ding, Hanna, Guzman-Becerra, Norma, Khanzadeh, Shahram, Li, Xiaoming, Gamelin, Laurence, Dubovsky, Jason, Nguyen, Cokey

المصدر: Transplantation and Cellular Therapy ; volume 29, issue 2, page S156-S157 ; ISSN 2666-6367

الاتاحة: http://dx.doi.org/10.1016/s2666-6367(23)00269-5
https://api.elsevier.com/content/article/PII:S2666636723002695?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S2666636723002695?httpAccept=text/plain

View record in BASE

5

Academic Journal

Multicenter, Open-Label, Phase 3 (P3) Study of Tabelecleucel (Tab-cel) for Solid Organ (SOT) or Allogeneic Hematopoietic Cell Transplant (HCT) Recipients with Epstein–Barr Virus-Driven Post Transplant Lymphoproliferative Disease (EBV+ PTLD) after Failure of Rituximab (R) or Rituximab and Chemotherapy (R + C) (ALLELE)

المؤلفون: Prockop, Susan E., Mahadeo, Kris M, Beitinjaneh, Amer, Choquet, Sylvain, Stiff, Patrick, Reshef, Ran, Satyanarayana, Gowri, Dahiya, Saurabh, Parmar, Hema, Ye, Wei, Gamelin, Laurence, Mehta, Aditi, Dinavahi, Rajani

المصدر: Transplantation and Cellular Therapy ; volume 28, issue 3, page S22-S23 ; ISSN 2666-6367

الاتاحة: http://dx.doi.org/10.1016/s2666-6367(22)00184-1
https://api.elsevier.com/content/article/PII:S2666636722001841?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S2666636722001841?httpAccept=text/plain

View record in BASE

6

Academic Journal

Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein–Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial

المساهمون: National Comprehensive Cancer Network, Atara Biotherapeutics

المصدر: The Lancet Oncology ; volume 25, issue 3, page 376-387 ; ISSN 1470-2045

الاتاحة: http://dx.doi.org/10.1016/s1470-2045(23)00649-6
https://api.elsevier.com/content/article/PII:S1470204523006496?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S1470204523006496?httpAccept=text/plain

View record in BASE

7

Academic Journal

Clinical Experience of Tabelecleucel in Patients with EBV+ Primary (PID) or Acquired Immunodeficiency (AID) Associated Lymphoproliferative Disease

المؤلفون: Nikiforow, Sarah, Baiocchi, Robert, Nasta, Sunita, Weng, Wen-Kai, Loeb, David, Mahadeo, Kris Michael, Whangbo, Jennifer, Phuong, Patrick, Navarro, Willis H., Gamelin, Laurence, Sun, Yan, Guzman-Becerra, Norma, Prockop, Susan E.

المصدر: Transplantation and Cellular Therapy ; volume 27, issue 3, page S198 ; ISSN 2666-6367

الاتاحة: http://dx.doi.org/10.1016/s2666-6367(21)00245-1
https://api.elsevier.com/content/article/PII:S2666636721002451?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S2666636721002451?httpAccept=text/plain

View record in BASE

8

Academic Journal

A Multicenter, Multicohort, Open-Label, Single Arm per Cohort, Phase II Study to Assess the Efficacy and Safety of Tabelecleucel in Patients with EBV-Associated Diseases Using an Adaptive Two-Stage Study Design

المؤلفون: Prockop, Susan E., Dinavahi, Rajani, Navarro, Willis H., Guzman-Becerra, Norma, Sun, Yan, Gamelin, Laurence

المصدر: Transplantation and Cellular Therapy ; volume 27, issue 3, page S431 ; ISSN 2666-6367

الاتاحة: http://dx.doi.org/10.1016/s2666-6367(21)00557-1
https://api.elsevier.com/content/article/PII:S2666636721005571?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S2666636721005571?httpAccept=text/plain

View record in BASE

9

Academic Journal

Clinical Experience of Tabelecleucel in Patients with Life-Threatening Complications of Epstein–Barr Virus Viremia

المؤلفون: Torno, Lilibeth, Dahlberg, Ann, Ghobadi, Armin, Stiff, Patrick, Reshef, Ran, Weng, Wen-Kai, Navarro, Willis H., Gamelin, Laurence, Dinavahi, Rajani, Sun, Yan, Guzman-Becerra, Norma, Prockop, Susan E.

المصدر: Transplantation and Cellular Therapy ; volume 27, issue 3, page S201-S202 ; ISSN 2666-6367

الاتاحة: http://dx.doi.org/10.1016/s2666-6367(21)00249-9
https://api.elsevier.com/content/article/PII:S2666636721002499?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S2666636721002499?httpAccept=text/plain

View record in BASE

10

Periodical

Tabelecleucel for EBV+PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol

المصدر: Blood Advances; June 2024, Vol. 8 Issue: 12 p3001-3012, 12p

Full Text Finder

11

Academic Journal

A Multicenter, Open Label, Phase 3 Study of Tabelecleucel for Solid Organ Transplant Subjects with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disorder (EBV+PTLD) after Failure of Rituximab or Rituximab and Chemotherapy (ALLELE)

المؤلفون: Prockop, Susan E, Hiremath, Minoti, Ye, Wei, Gamelin, Laurence, Navarro, Willis H., Mahadeo, Kris Michael

المصدر: Biology of Blood and Marrow Transplantation ; volume 26, issue 3, page S274 ; ISSN 1083-8791

الاتاحة: http://dx.doi.org/10.1016/j.bbmt.2019.12.444
https://api.elsevier.com/content/article/PII:S1083879119313734?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S1083879119313734?httpAccept=text/plain

View record in BASE

12

Patent

Protection against the neurotoxicity of oxaliplatin through the administration of calcium and magnesium

View record in USPTO Patent Applications

13

Periodical

Updated Efficacy and Safety of Tabelecleucel in Patients with Epstein-Barr Virus-Positive (EBV+) Leiomyosarcomas (LMS)

المؤلفون: Jiménez-Kurlander, Lauren S, Behr, Gerald, Bunin, Nancy J, Doubrovina, Ekaterina, Dinavahi, Rajani, Gamelin, Laurence, Ghobadi, Armin, Mascarenhas, Leo, Nikiforow, Sarah, O'Reilly, Richard J, Price, Anita, Shulkin, Barry, Srinivasan, Ashok, Suser, Stephanie, Wahlstrom, Justin, Xing, Baodong, Prockop, Susan

المصدر: Blood; November 2022, Vol. 140 Issue: 1, Number 1 Supplement 1 p7524-7526, 3p

Full Text Finder

14

Periodical

New and Updated Results from a Multicenter, Open-Label, Global Phase 3 Study of Tabelecleucel (Tab-cel) for Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV+PTLD) Following Allogeneic Hematopoietic Cell (HCT) or Solid Organ Transplant (SOT) after Failure of Rituximab or Rituximab and Chemotherapy (ALLELE)

المؤلفون: Mahadeo, Kris Michael, Baiocchi, Robert A., Beitinjaneh, Amer, Chaganti, Sridhar, Choquet, Sylvain, Dierickx, Daan, Dinavahi, Rajani, Gamelin, Laurence, Ghobadi, Armin, Guzman-Becerra, Norma, Joshi, Manher, Mehta, Aditi, Nikiforow, Sarah, Reshef, Ran, Ye, Wei, Prockop, Susan

المصدر: Blood; November 2022, Vol. 140 Issue: 1, Number 1 Supplement 1 p10374-10376, 3p

Full Text Finder

15

Periodical

New and Updated Results from a Multicenter, Open-Label, Global Phase 3 Study of Tabelecleucel (Tab-cel) for Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) Following Allogeneic Hematopoietic Cell (HCT) or Solid Organ Transplant (SOT) after Failure of Rituximab or Rituximab and Chemotherapy (ALLELE)

المؤلفون: Mahadeo, Kris Michael, Baiocchi, Robert A., Beitinjaneh, Amer, Chaganti, Sridhar, Choquet, Sylvain, Dierickx, Daan, Dinavahi, Rajani, Gamelin, Laurence, Ghobadi, Armin, Guzman-Becerra, Norma, Joshi, Manher, Mehta, Aditi, Nikiforow, Sarah, Reshef, Ran, Ye, Wei, Prockop, Susan

المصدر: Blood; November 2022, Vol. 140 Issue: Supplement 1 p10374-10376, 3p

Full Text Finder

16

Academic Journal

Thromboembolism in patients with immune thrombocytopenia (ITP): a meta-analysis of observational studies

المؤلفون: Langeberg, Wendy J., Schoonen, W. Marieke, Eisen, Melissa, Gamelin, Laurence, Stryker, Scott

المساهمون: Amgen Inc.

المصدر: International Journal of Hematology ; volume 103, issue 6, page 655-664 ; ISSN 0925-5710 1865-3774

الاتاحة: http://dx.doi.org/10.1007/s12185-016-1974-6
http://link.springer.com/content/pdf/10.1007/s12185-016-1974-6.pdf
http://link.springer.com/article/10.1007/s12185-016-1974-6/fulltext.html
http://link.springer.com/content/pdf/10.1007/s12185-016-1974-6

View record in BASE

17

Academic Journal

Effectiveness and safety outcomes in patients with EBV + PTLD treated with allogeneic EBV-specific T-cell immunotherapy (tabelecleucel) under an expanded access program (EAP) in Europe.

المؤلفون: Choquet, Sylvain, Clark, Andrew, Renard, Cécile, Uttenthal, Ben, Chaganti, Sridhar, Trappe, Ralf Ulrich, Comoli, Patrizia, Duan, Xinyuan, Xing, Baodong, Wu, Charley, Gamelin, Laurence, Terwey, Jan-Henrik, Friedetzky, Anke, Dierickx, Daan

المصدر: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p7521-7521, 1p

18

Academic Journal

Clinical aspects and molecular basis of oxaliplatin neurotoxicity: Current management and development of preventive measures

المؤلفون: Gamelin, Erick, Gamelin, Laurence, Bossi, Laura, Quasthoff, Stefan

المصدر: Seminars in Oncology ; volume 29, issue 5 Suppl 15, page 21-33 ; ISSN 0093-7754

الاتاحة: http://dx.doi.org/10.1053/sonc.2002.35525

View record in BASE

19

Periodical

Exploring the Impact of Humoral Immunogenicity with Tabelecleucel (Tab-cel) for the Treatment of Epstein–Barr Virus Positive Post-Transplant Lymphoproliferative Disease (EBV+PTLD) Following Hematopoietic Stem Cell Transplantation (HCT) and Solid Organ Transplantation (SOT)

المؤلفون: Spindler, Tassja J., Ruiz, Fiona, Jehng, Tiffany, Ding, Hanna, Guzman-Becerra, Norma, Khanzadeh, Shahram, Li, Xiaoming, Gamelin, Laurence, Dubovsky, Jason, Nguyen, Cokey

المصدر: Transplantation and Cellular Therapy; February 2023, Vol. 29 Issue: 2, Number 2 Supplement 1 pS156-S157, 2p

Full Text Finder

20

Periodical

New and Updated Results from a Multicenter, Open-Label, Global Phase 3 (P3) Study of Tabelecleucel (Tab-cel) for Epstein–Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV+PTLD) Following Allogeneic Hematopoietic Cell (HCT) or Solid Organ Transplant (SOT) after Failure of Rituximab (R) or Rituximab and Chemotherapy (R+CT) (ALLELE)

المؤلفون: Beitinjaneh, Amer, Baiocchi, Robert, Chaganti, Sridhar, Choquet, Sylvain, Dierickx, Daan, Dinavahi, Rajani, Gamelin, Laurence, Ghobadi, Armin, Guzman-Becerra, Norma, Joshi, AJ, Mahadeo, Kris Michael, Mehta, Dr. Aditi, Nikiforow, Sarah, Reshef, Ran, Ye, Wei, Prockop, Susan

المصدر: Transplantation and Cellular Therapy; February 2023, Vol. 29 Issue: 2, Number 2 Supplement 1 pS21-S22, 2p

Full Text Finder

تنقيح النتائج